LiquiVent perflubron data

ALLP announced that Phase II findings with the agent showed reduced days on mechanical ventilation, and improved survival, but only in

Read the full 212 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE